Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1

NCT06532656 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV-1-infection

Interventions

DRUG: Lenacapavir
DRUG: BIC/LEN FDC

Sponsor

Gilead Sciences